| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.55 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.08 | 0.1 |